ArticleFrontiers in medicine2025

Toward the future management of patients with CML and Ph + ALL: real-world safety insights from dasatinib pharmacovigilance.

Zhen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.